Table 7.

CR Rate by Patient Characteristics

Patient Characteristics N%
Age  
 <55 (n = 60)  42  70%  
 ≥55 (n = 14)  9  64%  
Sex 
 Male (n = 43)  28  65%  
 Female (n = 31)  23 74%  
Race  
 White (n = 67)  46  69%  
 Other (n = 7)  5  71%  
Performance status  
 0 (n = 45) 32  71%  
 1 (n = 29)  19  66%  
B-symptoms 
 Yes (n = 29)  18  62%  
 No (n = 43)  32 74%  
 Missing (n = 2)  1  
Stage  
 II (n = 13) 8  62%  
 III/IV (n = 61)  43  70% 
International index  
 0-1 (n = 29)  20  69%  
 2-4 (n = 39)  26  67%  
 Missing (n = 6)  
Age adjusted international index  
 0-1 (n = 37)  25  68%  
 2 (n = 31)  21  68% 
 Missing (n = 6)  5  
Pathology  
 Follicular large cell (n = 10)  7  70%  
 Diffuse small cleaved (n = 1)  0%  
 Diffuse mixed (n = 6)  4  67%  
 Diffuse large cell (n = 37)  25  68%  
 Large cell immunoblastic (n = 17)  13  76%  
 Composite (n = 1)  1  100% 
 Other (Ki-1 anaplastic) (n = 2)  1  50% 
Patient Characteristics N%
Age  
 <55 (n = 60)  42  70%  
 ≥55 (n = 14)  9  64%  
Sex 
 Male (n = 43)  28  65%  
 Female (n = 31)  23 74%  
Race  
 White (n = 67)  46  69%  
 Other (n = 7)  5  71%  
Performance status  
 0 (n = 45) 32  71%  
 1 (n = 29)  19  66%  
B-symptoms 
 Yes (n = 29)  18  62%  
 No (n = 43)  32 74%  
 Missing (n = 2)  1  
Stage  
 II (n = 13) 8  62%  
 III/IV (n = 61)  43  70% 
International index  
 0-1 (n = 29)  20  69%  
 2-4 (n = 39)  26  67%  
 Missing (n = 6)  
Age adjusted international index  
 0-1 (n = 37)  25  68%  
 2 (n = 31)  21  68% 
 Missing (n = 6)  5  
Pathology  
 Follicular large cell (n = 10)  7  70%  
 Diffuse small cleaved (n = 1)  0%  
 Diffuse mixed (n = 6)  4  67%  
 Diffuse large cell (n = 37)  25  68%  
 Large cell immunoblastic (n = 17)  13  76%  
 Composite (n = 1)  1  100% 
 Other (Ki-1 anaplastic) (n = 2)  1  50% 
Close Modal

or Create an Account

Close Modal
Close Modal